Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R | Q15722 | 2/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | ATR | Q13535 | 1/20 | 0.42 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.40 |
| ▸ | MPO | P05164 | 1/20 | 0.40 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23440398 | 0.92 | LTB4R (0.41) | LTB4RAOC3CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL29769271 | 0.83 | ATR (0.40) | LTB4RAOC3CYP1A2CYP3A4CYP2D6 | |
| Ammonia Solution, Strong SCHEMBL557826 | 0.83 | MAOA (0.41) | AOC3CYP2D6ATRMAPKAPK2MPO | |
| SCHEMBL14898963 | 0.82 | LTB4R (0.46) | LTB4RAOC3CYP1A2CYP3A4CYP2D6 | |
| Ammonia Solution, Strong SCHEMBL5381714 | 0.81 | MPO (0.35) | MPO | |
| SCHEMBL21751424 | 0.81 | LTA4H (0.43) | MAPKAPK2MPO | |
| SCHEMBL30800174 | 0.81 | LTA4H (0.43) | MAPKAPK2MPO | |
| SCHEMBL13247444 | 0.81 | MAPKAPK2 (0.51) | LTB4RAOC3CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL22651726 | 0.81 | LTB4R (0.45) | LTB4RAOC3CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL23440396 | 0.81 | PRKDC (0.48) | CYP2D6ATR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239803-A1 | SYNTHESIS OF COELENTERAZINE | INTERNATIONAL PAPER COMPANY | 2024-07-18 | — | — | US | claimed |
| US-11939332-B2 | Synthesis of coelenterazine | INTERNATIONAL PAPER COMPANY (US) | 2024-03-26 | — | — | US | claimed |
| EP-3830088-A1 | SYNTHESIS OF COELENTERAZINE | International Paper Company (US) | 2021-06-09 | — | — | EP | claimed |
| US-11008326-B2 | Synthesis of coelenterazine | INTERNATIONAL PAPER COMPANY (US) | 2021-05-18 | — | — | US | claimed |
| US-20210070762-A1 | SYNTHESIS OF COELENTERAZINE | INTERNATIONAL PAPER COMPANY (US) | 2021-03-11 | — | — | US | claimed |
| CN-112368286-A | Synthesis of coelenterazine | 国际纸业公司 | 2021-02-12 | — | — | CN | claimed |
| US-10906911-B2 | — | — | 2021-02-02 | — | — | US | claimed |
| EP-3981839-B1 | COELENTERAZINE ANALOGS FOR USE IN LUCIFERASE-BASED ASSAYS | PROMEGA CORP (US) | 2025-08-20 | — | — | EP | disclosed |
| JP-2024153780-A | Synthesis of coelenterazine | インターナショナル・ペーパー・カンパニー | 2024-10-29 | — | — | JP | disclosed |
| US-20240239803-A1 | SYNTHESIS OF COELENTERAZINE | INTERNATIONAL PAPER COMPANY | 2024-07-18 | — | — | US | disclosed |
| US-20240239803-A1 | SYNTHESIS OF COELENTERAZINE | INTERNATIONAL PAPER COMPANY | 2024-07-18 | — | — | US | disclosed |
| US-20240239803-A1 | SYNTHESIS OF COELENTERAZINE | INTERNATIONAL PAPER COMPANY | 2024-07-18 | — | — | US | disclosed |
| CN-117924295-A | Furimazine derivative and preparation method and application thereof | 广州博鹭腾生物科技有限公司 | 2024-04-26 | — | — | CN | disclosed |
| EP-2454261-A1 | IMIDAZO[1,2-ALPHA]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE | Universita Degli Studi di Siena (IT) | 2012-05-23 | — | — | EP | disclosed |
| WO-2012040105-A2 | RENILLA/GAUSSIA TRANSFECTED CELLS AS A LIGHT SOURCE FOR IN-SITU PHOTODYNAMIC THERAPY OF CANCER | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2012-03-29 | — | — | WO | disclosed |
| US-20110288280-A1 | COELENTERAMIDE ANALOGS | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2011-11-24 | — | — | US | disclosed |
| US-20110288280-A1 | COELENTERAMIDE ANALOGS | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2011-11-24 | — | — | US | disclosed |
| US-20110288280-A1 | COELENTERAMIDE ANALOGS | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2011-11-24 | — | — | US | disclosed |
| WO-2011007314-A1 | IMIDAZO[1,2-α]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE | UNIVERSITÀ DEGLI STUDI DI SIENA (IT) | 2011-01-20 | — | — | WO | disclosed |
| WO-2011007314-A1 | IMIDAZO[1,2-α]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE | UNIVERSITÀ DEGLI STUDI DI SIENA (IT) | 2011-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288280-A1 | COELENTERAMIDE ANALOGS | CCKAR, ARSA, SI | LTB4R 1309/4885AOC3 1594/4885CYP1A2 2681/4885 |
| US-11939332-B2 | Synthesis of coelenterazine | ACHE, UROD, DDT | LTB4R 2170/4885AOC3 223/4885CYP1A2 144/4885 |
| US-11008326-B2 | Synthesis of coelenterazine | ACHE, UROD, DDT | LTB4R 2170/4885AOC3 223/4885CYP1A2 144/4885 |
| US-20240239803-A1 | SYNTHESIS OF COELENTERAZINE | ACHE, UROD, DDT | LTB4R 2170/4885AOC3 223/4885CYP1A2 144/4885 |
| US-20210070762-A1 | SYNTHESIS OF COELENTERAZINE | ACHE, UROD, DDT | LTB4R 2170/4885AOC3 223/4885CYP1A2 144/4885 |
| US-10906911-B2 | — | ACHE, UROD, SI | LTB4R 1847/4885AOC3 222/4885CYP1A2 235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.